We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.002 | 0.13% | 1.567 | 1.536 | 1.598 | 1.55 | 1.538 | 1.55 | 4,833,427 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.40 | 17.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/2/2024 08:32 | Abbey…try not to overstretch the finances | albert35911 | |
29/2/2024 08:30 | Buy HEMO sub 2p luckyabbeygale [but for cash and not with a SBET or CFD] | apotheki | |
29/2/2024 08:25 | HE1 was very gutting since if I hung onto them for one more day I would of had 30K profit instead of 10K profit. I like to add with all the other shares I did have a chance to gain 60 grand on them instead of being down 40 grand. As most had decent profits that all turned into losses by not selling out at the right time. I was up the most on Oriole at 0.5p and that fell back to 0.3p. | luckyabbeygale | |
29/2/2024 08:20 | To add to the points made by the other posters luckyabbeygale I would seriously avoid SBETs & CFDs on small caps as there is already more than enough risk around these types of plays. Use SBETs & CFDs for the likes of commodity, currency and perhaps FTSE100 shares ONLY [Just my opinion after years in the markets] | apotheki | |
29/2/2024 08:19 | Well done with your he1 10k abbey | albert35911 | |
29/2/2024 08:15 | Sub 2p buying opportunity Jibba Jabber [well it would be really rather rude not too!] | apotheki | |
29/2/2024 08:14 | Right now I am tempted to go as big as possible in Zephr. Already put in 5 grand nearly on spreadbet and cfds and could go bigger. | luckyabbeygale | |
29/2/2024 08:11 | roughandtumbleone, I put 90 percent of what I have left into oriole and I will hold them for years now. Looking at the next Greatland Gold on that one. The original plan was to only buy Oriole and if I had done that in the first place I would of more than double my inheritance and not been down 40K by dabbling in other stocks. I even had winners and still lost that much. Like being up 10 grand in HE1. | luckyabbeygale | |
29/2/2024 08:04 | Abbeygate Some advice about your inheritance.Stop jumping around in stocks and try to weather the storms. The list of stocks you've stated including QBT of which dropped to 0.8 and rose to 3.5 and all the way back to 1p within 3 months. Too many people jump around out of fear of losing their capital and in doing so lose their capital.Good luck and if you had sat tight with the shares you'd sold at 3p at a £6k loss you'd have seen a profit over the coming weeks. | roughandtumbleone | |
29/2/2024 07:55 | Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "We are extremely pleased to have raised these funds to allow us to progress our lead asset, HEMO-CAR-T, to clinical trials. This is a key development that represents the progression of Hemogenyx Pharmaceuticals to become a clinical stage company and the fundraise was crucial to enable us to progress toward clinical trials, the essential next step for the development of HEMO-CAR-T. I would like to thank new and existing shareholders for their support and for contributing to this sizeable fundraise in difficult market conditions. The recent lifting of the clinical hold by the FDA on our HEMO-CAR-T programme followed a great effort from everyone at Hemogenyx Pharmaceuticals for which I am very grateful." | apotheki | |
29/2/2024 07:54 | With your losses you should change your handle to veryunluckyabbeygale | albert35911 | |
29/2/2024 07:43 | Why not just announce the placing at 3p on the day of the FDA news?. | luckyabbeygale | |
29/2/2024 07:43 | Thanks Saint, not obvious enough for you not to buy some yesterday though eh? I flogged at the time of my post yesterday which was fortunate in hindsight, only because I wanted the cash for elsewhere. On the positive side, the company now has funds to take things forward, so the biggest red flag has gone for the near term. They really need to move forward now with trials, that is the only thing that will drive the share price. On the negative, unless the placing has gone to an II who wants to hold then you have a good sized overhang to get through and they likely to languish for the forseeable. Back on the watchlist. | premium beeks | |
29/2/2024 07:41 | Yeah maybe your right. What Hemo done is far worst than Langbar, Oxus Gold and Churchill Mining. All that I lost on but at least two was court cases and the other one felt that a scam in which it was. | luckyabbeygale | |
29/2/2024 07:40 | Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "We are extremely pleased to have raised these funds to allow us to progress our lead asset, HEMO-CAR-T, to clinical trials. This is a key development that represents the progression of Hemogenyx Pharmaceuticals to become a clinical stage company and the fundraise was crucial to enable us to progress toward clinical trials, the essential next step for the development of HEMO-CAR-T. I would like to thank new and existing shareholders for their support and for contributing to this sizeable fundraise in difficult market conditions. The recent lifting of the clinical hold by the FDA on our HEMO-CAR-T programme followed a great effort from everyone at Hemogenyx Pharmaceuticals for which I am very grateful." | apotheki | |
29/2/2024 07:38 | Maybe a slight change of user name is needed Abbeygale ;) | premium beeks | |
29/2/2024 07:38 | This is why I should of just stuck to being a one share person with my inheritance. Like I was just before I had my inheritance since it was all in oriole and if I just stuck to them I be up 120 grand instead of down 40 grand. | luckyabbeygale | |
29/2/2024 07:36 | Its was obvious a placing was coming.Inside trading was even stated in the RNS so why cant they do something about it. | saint in exile | |
29/2/2024 07:35 | About Hemogenyx Pharmaceuticals plc Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility. The Company is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as platform technologies that it uses as engines for novel product development. | apotheki | |
29/2/2024 07:35 | If it was not for my main holding in Oriole. I am certain I would of now only had about 30 grand left. | luckyabbeygale | |
29/2/2024 07:34 | I have lost 40 grand of my inheritance since October. With 85 grand left out of 125 grand. It is because I was caught out on Baron Oil, Hemo, Red Rock, Fusion Antibodies, Gene Drive, Music Magpie, Angel, C4XD Discovery, QBT and many more. The market has been the worst I ever seen it to be since I started in 1995. | luckyabbeygale | |
29/2/2024 07:34 | Good morning Jibba Jabber and yes well done for waiting. In light of todays OFFICIAL announcement confirming all those law breaking TROLLs posts....if you can buy any where close to the placing price then wow what a BUYING OPPORTUNITY. Don't think that it will last that long as the company now have the money in the bank and are clearly raring to go! Good luck fella! | apotheki | |
29/2/2024 07:30 | Even more interesting now. | jibba jabber |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions